<DOC>
	<DOC>NCT01225562</DOC>
	<brief_summary>This study is being carried out to see if a new drug called ticagrelor given twice daily in addition to the ASA therapy decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack, or stroke).</brief_summary>
	<brief_title>Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Person who had a heart attack within 1 3 years ago and at least one additional risk factor: Age â‰¥ 65 years old, Diabetes requiring medication, Documented history of 2nd prior MI (&gt;1 year ago). Angiographic evidence of multivessel CAD, and / or Chronic, nonend stage renal dysfunction. Females of childbearing potential must have a negative pregnancy test at enrollment Persons who are currently taking aspirin between 75 and 150 mg once daily Persons who are being treated with agents inhibiting blood clotting if the agent cannot be stopped at study start Persons who have planned coronary, cerebrovascular, or peripheral arterial Revascularization (invasive surgery) at study start Persons with known bleeding disorders Persons who need chronic oral anticoagulant therapy or chronic lowmolecularweight heparin Persons with a history of ischemic stroke Persons with a history of intracranial bleeding at any time, a tumor or blood vessel abnormality in the brain and/or spinal cord at any time, a history of surgery involving the brain or spinal cord within the last 5 years, or a history of bleeding from the gastrointestinal tract (eg, esophagus, stomach, colon, rectum) within the last 6 months or a major surgery within the last 30 days. Persons considered to be at risk of bradycardic events unless already treated with a permanent pacemaker Persons who have had open heart surgery within the past 5 years, unless the person had a heart attack after the surgery Persons with known severe liver disease Persons with kidney failure requiring dialysis Persons with life expectancy &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Heart attack</keyword>
	<keyword>Heart Disease</keyword>
	<keyword>Acute coronary syndrome</keyword>
	<keyword>ACS</keyword>
	<keyword>Cardiovascular Disease</keyword>
</DOC>